Influence of Pertussis Toxin Pretreatment on the Development of L-NAME-Induced Hypertension

被引:4
|
作者
Zicha, J. [1 ,2 ]
Kunes, J. [1 ,2 ]
Vrankova, S. [3 ]
Jendekova, L. [3 ]
Dobesova, Z. [1 ,2 ]
Pinterova, M. [1 ,2 ]
Pechanova, O. [1 ,3 ]
机构
[1] Acad Sci Czech Republ, Inst Physiol, Videnska 1083, CR-14220 Prague 4, Czech Republic
[2] Cardiovasc Res Ctr, Prague, Czech Republic
[3] Slovak Acad Sci, Inst Normal & Pathol Physiol, Bratislava, Slovakia
关键词
Sympathetic nervous system; Nitric oxide; Inhibitory G proteins; Blood pressure; NITRIC-OXIDE; ENHANCED EXPRESSION; BLOOD-PRESSURE; MECHANISMS; CAPTOPRIL; PROTEINS; BRAIN;
D O I
10.33549/physiolres.931898
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
High blood pressure (BP) of L-NAME hypertensive rats is maintained not only by the absence of nitric oxide (NO)dependent vasodilatation but also by the enhancement of both sympathetic and angiotensin II-dependent vasoconstriction. The aim of the present study was to evaluate the role of inhibitory G (G(i)) proteins, which are involved in tonic sympathetic vasoconstriction, in the pathogenesis of NO-deficient hypertension. We therefore studied BP response to chronic L-NAME administration (60 mg/kg/day for 4 weeks) in rats in which the in vivo inactivation of Gi proteins was induced by injection of pertussis toxin (PTX, 10 mu g/kg i.v.). The impairment of sympathetic vasoconstriction due to PTX-induced G(i) protein inactivation prevents the full development of NO-deficient hypertension because BP of PTX-treated rats subjected to chronic L-NAME administration did not reach hypertensive values. Nevertheless, chronic NO synthase inhibition per se is capable to increase moderately BP even in PTX-treated rats. Our data suggest that the sympathetic vasoconstriction is essential for the development of established NO-deficient hypertension.
引用
收藏
页码:751 / 755
页数:5
相关论文
共 50 条
  • [31] Spironolactone improves nitric oxide/cGMP pathway in L-NAME-induced hypertension
    Pechanova, O.
    Matuskova, J.
    Paulis, L.
    Jendekova, L.
    Kojsova, S.
    Simko, F.
    HYPERTENSION, 2006, 48 (04) : 773 - 773
  • [32] Role of oxidative stress in DOCA-salt and L-NAME-induced hypertension
    Choi, Ki Chul
    Cho, Jeong Won
    Bae, Woo Kyun
    Park, Jeong Woo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 44 - 44
  • [33] Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats
    Su-Ching Yang
    Hsin-Yi Yang
    Yi-Ching Yang
    Hsiang-Chi Peng
    Pei-Yin Ho
    European Journal of Nutrition, 2013, 52 : 601 - 608
  • [34] Ivabradine reversed nondipping heart rate in rats with l-NAME-induced hypertension
    Baka, Tomas
    Simko, Fedor
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (06) : 607 - 610
  • [35] Syringic acid ameliorates l-NAME-induced hypertension by reducing oxidative stress
    Subramanian Kumar
    Pichavaram Prahalathan
    Boobalan Raja
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 1175 - 1184
  • [36] Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension
    Simko, F
    Matuskova, J
    Luptak, I
    Krajcirovicova, K
    Kucharska, J
    Gvozdjakova, A
    Babal, P
    Pechanova, O
    LIFE SCIENCES, 2004, 74 (10) : 1211 - 1224
  • [37] Genetic control of renal damage in rats with L-NAME-induced hypertension.
    VanDokkum, RPE
    Jacob, HJ
    Provoost, AP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3100 - A3100
  • [38] Evidence that the central nervous system plays a role in L-NAME-induced hypertension
    Aleixandre, MA
    LopezMiranda, V
    Puerro, M
    Ortega, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 : P82 - P82
  • [39] Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension
    Pechánová, O
    Bernátová, I
    Babál, P
    Martínez, MC
    Kyselá, S
    Stvirtina, S
    Andriantsitohaina, R
    JOURNAL OF HYPERTENSION, 2004, 22 (08) : 1551 - 1559
  • [40] Effect of 20-HETE inhibition on L-NAME-induced hypertension in rats
    Ozen, Nur
    Ulker, Seher Nasircilar
    Ulker, Pinar
    Ozcan, Filiz
    Aslan, Mutay
    Senturk, Umit Kemal
    Basrali, Filiz
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2018, 40 (03) : 292 - 302